 |
Kalina introduces his book with provocative claims about cancer and its research today. The first claim is alarming enough: every third person is afflicted with cancer, and nearly every fourth person actually dies from it. A reader of this book likely has personal experience supporting these statistics. The author’s second claim is that the economic credo in the selection of potential research projects is to attain maximum profits in minimum time. Drug research has priority. Chapters 1 through 3 discuss how this affects professional clinicians and physicians. The book is dedicated to one of three Nobel Prize winners for the discovery of penicillin who experienced the early stages of big business determining research funds.
Remaining chapters present the concept and methodology introduced by Dr. Karel Fortýn called Autologous Tumor Immunizing Devascularisation (ATID) theory. His research proved ATID effective during animal and sample clinical testing on cancers with large, solid tumors. While chemotherapy works for certain cancers such as leukemia, it can actually harm immune system defenses needed for tumor removal. Fortýn’s technique surgically extracts the tumor but stitches off the blood supply to a remnant of cancer tissue. This blood-starved tissue alerts the patient’s immune system to destroy any cancer cells, at the site or elsewhere.
Because the author writes for two audiences (layman and professional) early chapters may seem repetitive, even argumentative. Excellent resources at the end of the book include a list of tables and figures along with a comprehensive index, although a glossary for the layman would have been a helpful addition. Still, this 340-page book has met Kalina’s aims to explain reasons for the prevailing attitude, arouse public and professional interest, and show that current therapeutic procedures actually remove or destroy the patient’s immune system rather than stimulating it. No reader will again think the same about cancer and its victims.
RECOMMENDED by the US Review